ailanthone has been researched along with Cancer of Stomach in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Hao, TF; He, YL; Hu, ZR; Huo, MY; Li, HF; Li, WG; Su, Q; Wang, CM; Wang, XK; Wu, W; Xiao, X; Zhang, CH; Zhang, HY; Zhang, YW; Zhao, GY | 1 |
| Chen, C; Chen, Y; He, Y; Ji, Z; Wei, C; Yang, X; Zhu, L | 1 |
2 other study(ies) available for ailanthone and Cancer of Stomach
| Article | Year |
|---|---|
Ailanthus Altissima-derived Ailanthone enhances Gastric Cancer Cell Apoptosis by Inducing the Repression of Base Excision Repair by Downregulating p23 Expression.
Topics: Ailanthus; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Damage; DNA Repair; Down-Regulation; Drug Discovery; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pyridinolcarbamate; Quassins; Stomach Neoplasms; X-ray Repair Cross Complementing Protein 1; Xenograft Model Antitumor Assays | 2021 |
Ailanthone induces G2/M cell cycle arrest and apoptosis of SGC‑7901 human gastric cancer cells.
Topics: Ailanthus; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; G2 Phase Cell Cycle Checkpoints; Humans; M Phase Cell Cycle Checkpoints; Proto-Oncogene Proteins c-bcl-2; Quassins; Stomach Neoplasms | 2017 |